285.00
285.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
LEVOZINT 500 TAB contains Levofloxacin 500 mg, a broad-spectrum fluoroquinolone antibiotic used to treat various bacterial infections, including those of the respiratory tract, urinary tract, skin, and gastrointestinal system. Manufactured under strict quality control by BLUEPILL EXPRESS, it ensures effective and safe treatment with once-daily dosing.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
LEVOZINT 500 TAB is an advanced antibacterial formulation containing Levofloxacin 500 mg, a potent synthetic broad-spectrum fluoroquinolone antibiotic. It is primarily indicated for the treatment of mild to severe bacterial infections affecting various parts of the body. This tablet formulation is produced with high precision by BLUEPILL EXPRESS, a global leader in third-party pharmaceutical manufacturing.
Levofloxacin, the active ingredient, is the L-isomer of ofloxacin, offering superior antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV—key enzymes required for bacterial DNA replication, transcription, and repair. This bactericidal action makes LEVOZINT 500 TAB highly effective in combating a wide range of Gram-positive and Gram-negative organisms.
Indications:
Community-acquired pneumonia
Acute bacterial sinusitis
Acute exacerbation of chronic bronchitis
Complicated and uncomplicated urinary tract infections (UTIs)
Pyelonephritis
Skin and soft tissue infections
Prostatitis
Infectious diarrhea
Certain cases of multidrug-resistant tuberculosis (as adjunct)
Pharmaceutical Details:
Composition: Levofloxacin 500 mg
Dosage Form: Film-coated oral tablet
Route: Oral administration
Appearance: Oval-shaped, light-yellow tablet (customizable)
Packaging: Blister or alu-alu packs, with multilingual export options
Shelf Life: Typically 24–36 months
Storage: Store below 25°C in a dry place away from light
Product Highlights:
Once-daily dosing for improved patient compliance
High oral bioavailability (>99%)
Effective against multi-resistant respiratory and urinary pathogens
Reliable tissue penetration, especially in lungs and urogenital tract
Rapid onset of action with sustained bactericidal levels